The 6 analysts offering 12-month price forecasts for Pharming Group NV have a median target of 21.38, with a high estimate of 40.00 and a low estimate of 17.51. The median estimate represents a +43.10% increase from the last price of 14.94.
The current consensus among 6 polled investment analysts is to Buy stock in Pharming Group NV. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.07
Reporting Date Oct 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.